Use preheader to tease the email content, the length should be at least
90 to 100 characters.
Message below is a paid advertisement. Content is provided by the sponsor.
<http://www.biopharminternational.com/>
------------------------------------------------------------------------
  	
 
View this email in your browser
<http://creative.advanstar.com/bp/2017/Jul17/Agilent_2517/index.html> or
as plain text
<http://creative.advanstar.com/bp/2017/Jul17/Agilent_2517/text.txt>
Agilent Technologies

<http://www.agilent.com/>
	 

IN PEPTIDE MAPPING, THREE QUESTIONS ARE CRITICAL
<http://www.agilent.com/en-us/promotions/biopharma#peptidemapping>
	

Peptide mapping is vital to understanding the structure of proteins and
monitoring the genetic stability of recombinant cell lines. To create
effective, high-quality biotherapeutics, you have to get this right.

Renowned for accuracy and reliability, Agilent offers a comprehensive
set of technologies—instruments, columns, databases, methods, and
more—to ensure that every element of your peptide-mapping workflow
performs as it should, time after time.

You’ll be able to confirm protein sequences and identify modifications
with confidence. In fact, with Agilent’s highly efficient
peptide-mapping workflow, you’ll be able to do less and get more
done—without sacrificing precision.

BE AGILENT SURE
<http://www.agilent.com/en-us/promotions/biopharma#peptidemapping> IN
PEPTIDE MAPPING
	

<http://www.agilent.com/en-us/promotions/biopharma#peptidemapping> 	 

For Research Use Only. Not for use in diagnostic procedures.
  	 
  	
CONNECT WITH AGILENT 	Facebook
<https://www.facebook.com/Agilent.Tech> 	  	Twitter
<http://twitter.com/agilent> 	  	LinkedIn
<https://www.linkedin.com/showcase/6630257> 	  	Youtube
<https://www.youtube.com/user/agilent> 	 

	 
  	  	 
  	Agilent Home <http://www.agilent.com/>  |  About Agilent
<http://www.agilent.com/about>  |  Legal
<http://www.agilent.com/go/terms>  |  Subscriptions
<http://www.agilent.com/en-us/newsletters>  |  5301 Stevens Creek Blvd,
Santa Clara CA 95051, USA

Agilent is committed to respecting and protecting your privacy. To view
the promises that we make to you regarding your personal information,
please view Agilent's privacy statement
<http://www.agilent.com/go/privacy>. For questions related to privacy,
please send your inquiry to privacy_advocate@agilent.com
<mailto:privacy_advocate@agilent.com>. If you prefer not to receive
promotional e-mails from Agilent in the future, you can unsubscribe
<http://www.agilent.com/cs/agilent/en-us/globaloptout/form> at any time.
You can also update
<http://www.agilent.com/en-us/contact-us/na-profileupdate> your e-mail
address, contact information, or interest profile to ensure you receive
the most relevant information.

© Agilent Technologies, Inc. 2017


You received this email because you are a customer of BIOP, a UBM
publication. You are on the mailing list as %%emailaddress%%
<http://creative.advanstar.com/bp/2017/Jul17/Agilent_2517/%%emailaddress%%>.